IL2 and neoplasm: Similarly, Yang et al. [33] reported that APS at doses of 100 and 400 mg/kg significantly suppressed tumour growth, increased body weight and immune organ indices in tumour-bearing mice, enhanced macrophage phagocytic function, and promoted the secretion of IL-2, IL-12, and TNF-α, while reducing IL-10 levels.